| Ms Vivian Leslie Lindfield, MD | |
|
180 Park Club Lane, Suite 100, Williamsville, NY 14221-5258 | |
| (716) 632-7465 | |
| (716) 632-7464 |
| Full Name | Ms Vivian Leslie Lindfield |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 180 Park Club Lane, Suite 100, Williamsville, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356320345 | NPI | - | NPPES |
| 198215 | Other | NY | GHI |
| 161000580 | Other | NY | EMPIRE |
| 000527431003 | Other | NY | HEALTH NOW |
| 02504772 | Medicaid | NY | |
| 161000580 | Other | NY | NORTH AMERICAN PREFERRED |
| 00026456702 | Other | NY | UNIVERA |
| 1790976 | Other | NY | IHA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 001986-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erie County Medical Center | Buffalo, NY | Hospital |
| Mount St. Mary's Hospital & Health Center | Lewiston, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vivian L Lindfield Md Pc | 8729140272 | 2 |
News Archive
Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.
National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.
Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.
› Verified 3 days ago
| Entity Name | Vivian L Lindfield Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225280217 PECOS PAC ID: 8729140272 Enrollment ID: O20081218000051 |
News Archive
Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.
National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.
Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.
› Verified 3 days ago
| Entity Name | General Physician Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093959322 PECOS PAC ID: 9537213079 Enrollment ID: O20090818000154 |
News Archive
Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.
National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.
Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Vivian Leslie Lindfield, MD 180 Park Club Lane, Suite 100, Williamsville, NY 14221-5258 Ph: (716) 632-7465 | Ms Vivian Leslie Lindfield, MD 180 Park Club Lane, Suite 100, Williamsville, NY 14221-5258 Ph: (716) 632-7465 |
News Archive
Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.
National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.
Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.
› Verified 3 days ago
Jonathan C Reynhout, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6333 Main St, Williamsville, NY 14221 Phone: 716-631-8400 Fax: 716-631-8408 | |
Dr. Ajay N Panchal, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6044 Main St Ste 110, Williamsville, NY 14221 Phone: 716-833-7112 | |
Joseph Anthony Caruana, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 30 N Union Rd, Ste 104, Williamsville, NY 14221 Phone: 716-565-3990 Fax: 716-565-3988 | |
Jessica Martinolich, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1150 Youngs Rd Ste 205, Williamsville, NY 14221 Phone: 716-636-9004 | |
Lyndsay Ann Gutierrez-panchal, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 180 Park Club Ln, Williamsville, NY 14221 Phone: 716-332-6834 Fax: 716-332-6856 | |
Dr. Eyad M Wohaibi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2150 Wehrle Dr Ste 300, Williamsville, NY 14221 Phone: 716-453-5200 Fax: 716-710-8075 | |
Dr. Stuti Tambar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 192 Park Club Ln Ste 120, Williamsville, NY 14221 Phone: 716-422-0010 |